EORTC 18961: Post-operative adjuvant ganglioside GM2-KLH21 vaccination treatment vs observation in stage II (T3-T4N0M0) melanoma: 2nd interim analysis led to an early disclosure of the results

被引:33
作者
Eggermont, A. M.
Suciu, S.
Ruka, W.
Marsden, J.
Testori, A.
Corrie, P.
Aamdal, S.
Ascierto, P. A.
Patel, P.
Spatz, A.
机构
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] European Org Res Treatment Canc, Brussels, Belgium
[3] M SK Mem Canc Ctr, Warsaw, Poland
[4] Univ Birmingham, Birmingham, W Midlands, England
[5] European Inst Oncol, Milan, Italy
[6] Addenbrookes Hosp, Ctr Oncol, Cambridge, England
[7] Norwegian Radium Hosp, Oslo, Norway
[8] Pascale Natl Canc Inst, Naples, Italy
[9] St James Hosp, Leeds, W Yorkshire, England
[10] Inst Gustave Roussy, Villejuif, France
关键词
D O I
10.1200/jco.2008.26.15_suppl.9004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9004
引用
收藏
页数:1
相关论文
empty
未找到相关数据